Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people. (2023)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/fampra/cmac094
PubMed Identifier: 36003039
Publication URI: http://europepmc.org/abstract/MED/36003039
Type: Journal Article/Review
Volume: 40
Parent Publication: Family practice
Issue: 2
ISSN: 0263-2136